Works Cited

1. Hunt M. Basic Virology: Replication of Viruses. Available at http://www.microbiologybook.org/mhunt/replicat.htm. Last accessed April 19, 2017.

2. Golla K, Epstein JB, Cabay RJ. Liver disease: current perspectives on medical and dental management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;98(5):516-521.

3. Little JW, Falace DA, Miller C, Rhodus NL. Little and Falace's Dental Management of the Medically Compromised Patient. 8th ed. St. Louis, MO: Mosby, Inc.; 2012.

4. Takahashi M, Kuusakai S, Mizuo H, et al. Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) is highly specific for diagnosis of acute HEV infection. J Clin Microbiol. 2005;43(1):49-56.

5. Shetty K, Husain KM. Hepatitis A-G: review for the general dental practitioner. J Greater Houston Dental Soc. 2007;79(5):12-21.

6. Centers for Disease Control and Prevention. Hepatitis A: General Information. Available at https://www.cdc.gov/hepatitis/hav/pdfs/hepageneralfactsheet.pdf. Last accessed April 19, 2017.

7. Centers for Disease Control and Prevention. Hepatitis A Questions and Answers for Health Professionals. Available at https://www.cdc.gov/hepatitis/HAV/HAVfaq.htm. Last accessed April 19, 2017.

8. Centers for Disease Control and Prevention. Hepatitis B: General Information. Available at https://www.cdc.gov/hepatitis/HBV/PDFs/HepBGeneralFactSheet.pdf. Last accessed April 19, 2017.

9. Molinari JA. What is the significance for dental professionals of the recently documented case of patient-to-patient transmission of hepatitis B? J Canadian Dent Assoc. 2007;73(10):911-912.

10. Redd JT, Baumbach J, Kohn W, Nainan O, Khristova M, Williams I. Patient-to-patient transmission of hepatitis B virus associated with oral surgery. J Infect Dis. 2007;195(9):1311-1314.

11. Occupational Health and Safety Administration. OSHA Fact Sheet: Hepatitis B Vaccination Protection. Available at http://www.osha.gov/OshDoc/data_BloodborneFacts/bbfact05.pdf. Last accessed April 19, 2017.

12. Centers for Disease Control and Prevention. Hepatitis B FAQs for Health Professionals. Available at https://www.cdc.gov/hepatitis/HBV/HBVfaq.htm. Last accessed April 19, 2017.

13. Thoelen S, Van Damme P, Leentvaar-Kuypers, et al. The first combined vaccine against hepatitis A and B: an overview. Vaccine. 1999;17(13-14):1657-1662.

14. Wynn RL, Meiller TF, Crossley HL. Drug Information Handbook for Dentistry. 19th ed. Hudson, OH: Lexi-Comp; 2013.

15. Hezard N, Metz D, Nazeyrollas P, et al. Use of the PFA-100 apparatus to assess platelet function in patients undergoing PTCA during and after infusion of cE3 Fab in the presence of other antiplatelet agents. Thromb Haemost. 2000;83:540-544.

16. Malamed SF. Handbook of Local Anesthesia. 6th ed. St. Louis, MO: Mosby, Inc.; 2012.

17. Centers for Disease Control and Prevention. Hepatitis D. Available at https://www.cdc.gov/hepatitis/HDV/index.htm. Last accessed April 19, 2017.

18. Centers for Disease Control and Prevention. Hepatitis C. FAQs for Health Professionals. Available at https://www.cdc.gov/hepatitis/hcv/hcvfaq.htm. Last accessed April 19, 2017.

19. Modi AA, Liang TJ. Hepatitis C: a clinical review. Oral Diseases. 2008;14(1):10-14.

20. Centers for Disease Control and Prevention. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR. 2001;50(RR-5):1-43.

21. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR. 1998;47(RR19):1-39.

22. U.S. Food and Drug Administration. Hepatitis B and C Treatments. Available at https://www.fda.gov/forpatients/illness/hepatitisbc/ucm408658.htm. Last accessed April 19, 2017.

23. Hepatitis C Online. Hepatitis C Treatments: FDA-Approved. Available at http://www.hepatitisc.uw.edu/page/treatment/drugs. Last accessed April 19, 2017.

24. Lexi-Comp Online. Available at http://online.lexi.com/lco/action/home. Last accessed April 19, 2017.

25. U.S. Food and Drug Administration. Drugs@FDA: FDA Approved Drug Products. Available at https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm. Last accessed April 19, 2017.

26. Pianko S, McHutchison JG. Treatment of hepatitis C with interferon and ribavirin. J Gastroenterol Hepatol. 2000;15(6):581-586.

27. Centers for Disease Control and Prevention. Hepatitis E FAQs for Health Professionals. Available at https://www.cdc.gov/hepatitis/HEV/HEVfaq.htm. Last accessed April 19, 2017.

28. Centers for Disease Control and Prevention. HIV Surveillance Report, 2015. Available at https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2015-vol-27.pdf. Last accessed April 12, 2017.

29. Fauci AS, Lane HC. HIV disease: AIDS and related disorders. In: Harrison's Online Principles of Medicine. 18th ed. New York, NY: McGraw-Hill; 2012.

30. Silverman S Jr. Color Atlas of Oral Manifestations of AIDS. 2nd ed. St. Louis, MO: Mosby, Inc.; 1996.

31. Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents: Recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Available at https://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. Last accessed April 19, 2017.

32. Newman MG, van Winkelhoff AJ. Antibiotic and Antimicrobial Use in Dental Practice. 2nd ed. New York, NY: Quintessence Publishing Co, Inc.; 2001.

33. Centers for Disease Control and Prevention. Shingles (Herpes Zoster). Available at https://www.cdc.gov/shingles/hcp/clinical-overview.html. Last accessed April 19, 2017.

34. Topazian RG, Goldberg MH, Hupp JR. Oral and Maxillofacial Infections. 4th ed. Philadelphia, PA: W.B. Saunders Co.; 2002.

35. Johns Hopkins Medicine. Epstein-Barr Virus. Available at https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545067/all/Epstein_Barr_virus. Last accessed April 19, 2017.

36. Godshall S, Kirchner J. Infectious mononucleosis: complexities of a common syndrome. Postgrad Med. 2000;107(7):175-179, 183-184, 186.

37. Bailey R. Diagnosis and treatment of infectious mononucleosis. Am Fam Physician. 1994;49(4):879-888.

38. Centers for Disease Control and Prevention. Epstein-Barr Virus and Infectious Mononucleosis. Available at https://www.cdc.gov/epstein-barr/about-mono.html. Last accessed April 19, 2017.

39. Centers for Disease Control and Prevention. Epstein-Barr Virus and Infectious Mononucleosis: References and Resources. Available at https://www.cdc.gov/epstein-barr/references.html. Last accessed April 19, 2017.

40. Tyring S (ed). Mucosal Immunology and Virology. London: Springer-Verlag; 2006.

41. Lynch DP. Hairy Leukoplakia. Available at http://emedicine.medscape.com/article/279269-overview. Last accessed April 19, 2017.

42. Glick M (ed). Clinician's Guide to Treatment of HIV-Infected Patients. 3rd ed. Baltimore, MD: American Academy of Oral Medicine; 2001.

43. New York State Department of Health AIDS Institute. Primary Care for People Living with HIV. Available at https://www.health.ny.gov/diseases/aids/providers/standards/support_services_providers/docs/primary_care.pdf. Last accessed April 19, 2017.

44. Burkitt DP. The discovery of Burkitt's lymphoma. Cancer. 1983;51(10):1777-1786.

45. Kanbar AH. Burkitt Lymphoma and Burkitt-Like Lymphoma. Available at http://emedicine.medscape.com/article/1447602-overview. Last accessed April 19, 2017.

46. Kasamon YL, Swinnen LJ. Treatment advances in adult Burkitt lymphoma and leukemia. Curr Opin Oncol. 2004;16(5):429-435.

47. Centers for Disease Control and Prevention. Cytomegalovirus (CMV) and Congenital CMV Infection. Available at http://www.cdc.gov/cmv/overview.html. Last accessed April 19, 2017.

48. Syrjanen S, Leimola-Virtanen R, Schmidt-Westerhausen A, Reichart PA. Oral ulcers in AIDS patients frequently associated with cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infection. J Oral Pathol Med. 1999;28(5):204-209.

49. Glick M, Cleveland DB, Salkin LM, Alfaro-Miranda M, Fielding AF. Intra-oral cytomegalovirus and HIV-associated periodontitis in a patient with acquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol. 1991;72(6):716-720.

50. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. N Engl J Med. 1995;332:1181-1185.

51. Rose LJ. Kaposi Sarcoma. Available at http://emedicine.medscape.com/article/279734-overview. Last accessed April 19, 2017.

52. Lucatorto FM, Sapp JP. Treatment of oral Kaposi's sarcoma with a sclerosing agent in AIDS patients: a preliminary study. Oral Surg Oral Med Oral Pathol. 1993;75(2):192-198.

53. Stebbing J, Portsmouth S, Gazzard B. How does HAART lead to the resolution of Kaposi's sarcoma? J Antimicrob Chemother. 2003;51(5):1095-1098.

54. Schiødt M. HIV-associated salivary gland disease: a review. Oral Surg Oral Med Oral Pathol. 1992;73(2):164-167.

55. Tiwari A, Kini H, Pai RR, Rau AR. HIV lymphadenitis of the salivary gland: a case with cytological and histological correlation.J Cytol. 2009:26(4):146-148.

56. Lacovou E, Vlastarakos PV, Papacharalampous G, Kampessis G, Nikolopoulos TP. Diagnosis and treatment of HIV-associated manifestations in otolaryngology. Infect Dis Rep. 2012;4(1):e9.

57. Mandel L, Vakkas J. Parotid enlargement in patient with HIV. N Y State Dent J. 2005;71(1):44-46.

58. zur Hausen H. Papillomaviruses in human cancers. Proc Assoc Am Physicians. 1999;111(6):581-587.

59. Eversole LR. Papillary lesions of the oral cavity: relationship to human papillomaviruses. J Calif Dent Assoc. 2000;28(12):922-927.

60. Scully C, Epstein J, Porter S, Cox M. Viruses and chronic disorders involving the human oral mucosa. Oral Surg Oral Med Oral Pathol. 1991;72(5):537-544.

61. Ghadishah D. Genital Warts. Available at http://emedicine.medscape.com/article/763014-overview. Last accessed April 19, 2017.

62. Kellokoski J, Syrjanen S, Syrjanen K, Yliskoski M. Oral mucosal changes in women with genital HPV infection. J Oral Pathol Med. 1990;19(3):142-148.

63. Eversole LR, Laipis PJ. Oral squamous papillomas: detection of HPV DNA by in situ hybridization. Oral Surg Oral Med Oral Pathol. 1988;65(5):545-550.

64. Scully C, Flint SR, Porter SR. Oral Diseases. 2nd ed. St. Louis, MO: Mosby, Inc.; 1996.

65. Harris AM, van Wyk CW. Heck's disease (focal epithelial hyperplasia): a longitudinal study. Community Dent Oral Epidemiol. 1993;21(2):82-85.

66. Padayachee A, van Wyk CW. Human papillomavirus (HPV) DNA in focal epithelial hyperplasia by in situ hybridization. J Oral Pathol Med. 1991;20(5):210-214.

67. University of California, San Francisco. Oral Manifestations of HIV. Available at http://hivinsite.ucsf.edu/InSite?page=kb-04-01-14#S3.3X. Last accessed April 19, 2017.

68. Centers for Disease Control and Prevention. HPV and Cancer. Available at https://www.cdc.gov/cancer/hpv/basic_info. Last accessed April 19, 2017.

69. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinoma worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14(2):467-475.

70. Centers for Disease Control and Prevention. Measles (Rubeola): For Travelers. Available at https://www.cdc.gov/measles/travelers.html. Last accessed April 19, 2017.

71. Chen SSP. Measles. Available at http://emedicine.medscape.com/article/966220-overview. Last accessed April 19, 2017.

72. Centers for Disease Control and Prevention. Measles (Rubeola): Signs and Symptoms. Available at https://www.cdc.gov/measles/about/signs-symptoms.html. Last accessed April 19, 2017.

73. Freed GL, Clark SJ, Butchart AT, Singer DC, Davis MM. Parental vaccine safety concerns in 2009. Pediatrics. 2010;125(4):654-659.

74. Centers for Disease Control and Prevention. Measles (Rubeola): For Healthcare Professionals: Treatment. Available at https://www.cdc.gov/measles/hcp/index.html. Last accessed April 19, 2017.

75. World Health Organization. Weekly Epidemiological Rec. 2009;35(84):349-360.

76. Centers for Disease Control and Prevention. Update: mumps outbreak––New York and New Jersey, June 2009–January 2010. MMWR. 2010;59(5):125-129.

77. Defendi GL. Mumps. Available at http://reference.medscape.com/article/966678-overview. Last accessed April 19, 2017.

78. Ito M, Go T, Okuno T, Mikawa H. Chronic mumps virus encephalitis. Pediatr Neurol. 1991;7(6):467-470.

79. Hooi PS, Chua BH, Lee CS, Lam SK, Chua KB. Hand, foot, and mouth disease: University of Malaya Medical Centre experience. Med J Malaysia. 2002;57(1):88-91.

80. Centers for Disease Control and Prevention. Hand, Foot, and Mouth Disease (HFMD). Available at https://www.cdc.gov/hand-foot-mouth/about/index.html. Last accessed April 19, 2017.

81. Gompf SG. Herpangina. Available at http://emedicine.medscape.com/article/218502-overview. Last accessed April 19, 2017.

Evidence-Based Practice Recommendations Citations

1. National Clinical Guideline Centre. Hepatitis B (Chronic): Diagnosis and Management of Chronic Hepatitis B in Children, Young People, and Adults. London: National Institute for Health and Care Excellence; 2013. Summary retrieved from National Guideline Clearinghouse at https://www.guideline.gov/summaries/summary/46933. Last accessed May 8, 2017.

2. Bower M, Palfreeman A, Alfa-Wali M, et al. British HIV Association guidelines for HIV-associated malignancies 2014. HIV Med. 2014;15(Suppl 2):1-92. Summary retrieved from National Guideline Clearinghouse at https://www.guideline.gov/summaries/summary/47858. Last accessed May 8, 2017.

3. Lacchetti C, Waldron J, Perez-Ordonez B, et al. Routine HPV Testing in Head and Neck Squamous Cell Carcinoma. Toronto: Cancer Care Ontario; 2013. Summary retrieved from National Guideline Clearinghouse at https://www.guideline.gov/summaries/summary/47075. Last accessed May 8, 2017.


Copyright © 2017 NetCE, P.O. Box 997571, Sacramento, CA 95899-7571
Mention of commercial products does not indicate endorsement.